Pharmaceutical Treatment
AIDS, DISORDERS
The expenditures originating directly from treating medical conditions or disorders, such as those related to the consumption of drugs (eg, frequency and dose) or materials and aids, were considered in 67% (12/18) of the studies [In some cases, DTx interventions have been shown to improve treatment adherence [In other cases, the clinical benefits of DTx treatments may be able to reduce or eliminate the need for pharmacotherapies, thereby lowering total medical expenditures. However, Nordyke et al [